Takeda Pharmaceutical Co - ADR XNYS: TAK

Takeda Pharmaceutical Co - ADR Live Stock Price Today, Share Analysis and Chart

Name: Takeda Pharmaceutical Co - ADR: Is Infosys Ltd. worth buying?
Item: Takeda Pharmaceutical Co - ADR
Rating: 2.353139
Author: Trendlyne DVM scores

Expensive Performer

about

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, whi...

13.60 -0.72 (-5.03%)

52W high on Jul 01, 2025

15.9M

XNYS Volume

High volume+loss today

XNYS 30 Jul, 2025 4:17 PM (EDT)

Board Meeting

The next board meeting for Takeda Pharmaceutical Co - ADR is on 31 Jul 2025 for the purpose of Takeda Pharmaceutical Co Ltd First Quarter Earnings Result for 2025 See details

High Financial Strength

55.6 / 100

Expensive Valuation

29.5 / 100

Technically Neutral

47.6 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 24%

4 analysts

Takeda Pharmaceutical Co -... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..